Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4967)
All Articles published online
|
Publishing Process of This Article
|
Jun 26, 2023 (publication date) through Oct 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Cijauskaite E, Kazenaite E, Strainiene S, Sadauskaite G, Kurlinkus B. Nivolumab-induced tumour-like gastritis: A case report. World J Clin Cases 2023; 11(18): 4350-4359 [PMID: 37449232 DOI: 10.12998/wjcc.v11.i18.4350] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Cijauskaite E, Kazenaite E, Strainiene S, Sadauskaite G, Kurlinkus B. Nivolumab-induced tumour-like gastritis: A case report. World J Clin Cases 2023; 11(18): 4350-4359 [PMID: 37449232 DOI: 10.12998/wjcc.v11.i18.4350] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i18/4350.htm |
| Number | Citing Articles |
| 1 |
Koki Tanaka, Toshiyuki Morisawa, Norio Katayama, Kazuki Inoue, Daiki Fumihara, Megumi Takagi, Tomoya Sako, Kenji Momose, Mari Noda, Keisuke Furumatsu. A Case of Severe Immune Checkpoint Inhibitor-associated Gastritis Treated with Steroids and Infliximab. Internal Medicine 2025; doi: 10.2169/internalmedicine.5736-25
|
| 2 |
Haibo Lei, Wei Sun, Xiang Liu, Chunjiang Wang. Clinical Characteristics and Outcomes of
Pembrolizumab Induced Gastritis: A Systematic Review of the Literature. Journal of Gastrointestinal Cancer 2024; 55(3): 1 doi: 10.1007/s12029-024-01067-x
|
| 3 |
|
| 4 |
|